相关实验视频

Updated: Jun 9, 2025

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

在膝关节骨关节炎中准TRPV1疼痛通路

Ali Mobasheri^1,2,3,4, François Rannou^5,6,7, Stefan Ivanavicius⁸

¹Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.

Expert opinion on therapeutic targets

|October 25, 2024

概括

针对短暂受体潜在化物1 (TRPV1) 受体的新型疗法在治疗膝关节骨关节炎 (KOA) 疼痛方面表现有前途. 关节内TRPV1激动剂为缓解疼痛提供了直接的方法,可能避免全身副作用.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
整形外科整形外科整形外科

背景情况:

膝关节骨关节炎 (KOA) 由于其日益流行,对有效的疼痛管理存在重大未满足的需求.
暂时受体潜在化物1 (TRPV1) 受体在疼痛信号中至关重要,并且在膝关节节痛感受体中大量存在.

研究的目的:

探索了解KOA中膝关节内化的进展.
研究TRPV1表达神经元在KOA疼痛中的作用.
审查开发用于KOA治疗的TRPV1调节器的进展情况.

主要方法:

关于疼痛通路中TRPV1受体功能的当前文献的综述.
对KOA.TRPV1调节器的临床前和临床数据的分析.
探索TRPV1激动剂的关节内药物输送策略.

主要成果:

膝盖中的TRPV1表达性感受体是KOA疼痛的可行目标.
TRPV1激动剂已经显示出临床进展,素和树脂毒素提供了概念验证.
关节内给药允许有针对性的输送,可能减轻与TRPV1抗剂相关的全身副作用.

结论:

向TRPV1受体,特别是用关节内激动剂,代表了对KOA疼痛的有前途的治疗策略.
进一步开发TRPV1调节器可以为管理KOA提供一种变革性的方法,解决当前止痛药的局限性.

关键词:

这是一种TRPV1激动剂.在内化过程中,内化是内化.这是一个关节内关节内关节内关节.一个可怕的感受器.骨关节炎是一种关节炎.疼痛疼痛疼痛疼痛树脂胺毒素 (resiniferatoxin) 是一种有毒的物质.暂时的受体潜力瓦尼洛伊德 1

更多相关视频

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...